GGrantIndex
Sort

51,593 grants matching hepatitis

The Development of TGR5 Antagonists for the Treatment of Cholangiopathies

$491,856
Steven H Olson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · DK

Arachidonate Products and CYP1A in Dioxin Toxicity

$491,780
Arleen B. Rifkind · Weill Medical Coll Of Cornell Univ · R01 · FY2007 · ES

Melanocortin-3 Receptor Regulation of Physical Activity and Metabolism

$491,769
Andrew Alistair Butler · Scripps Florida · R01 · FY2012 · DK

HIV-sensory neuropathies:risk factors, immunopathology

$491,710
Johns Hopkins University · R01 · FY2003 · NS

DAT-Emulating target trials with big data to strengthen the evidence base for the clinical management of opioid use disorder

$491,661
Bohdan Nosyk · Simon Fraser University · R01 · FY2022 · DA

Liver Pathobiology: insights through the lens of rare diseases

$491,654
Silvia Vilarinho · Yale University · R01 · FY2023 · DK

Liver Pathobiology: insights through the lens of rare diseases

$491,654
Silvia Vilarinho · Yale University · R01 · FY2025 · DK

Hepatocyte Abca1, cholesterol trafficking, and lipid mobilization

$491,586
John S Parks · Wake Forest University Health Sciences · R01 · FY2020 · HL

Contributions of Hepatic and Intestinal Pathways to Cholesterol Excretion

$491,578
Gregory A Graf · University Of Kentucky · R01 · FY2025 · DK

Systems Biology Approach to Analysis of Vaccine Response in Healthy Individuals

$491,578
Anna Karolina Palucka · Baylor Research Institute · U19 · FY2013 · AI

Human mechanisms of virus persistence in an AAV-based mouse model of chronic HBV infection

$491,566
Michael D Robek · Albany Medical College · R01 · FY2023 · AI

Human mechanisms of virus persistence in an AAV-based mouse model of chronic HBV infection

$491,566
Michael D Robek · Albany Medical College · R01 · FY2021 · AI

Human mechanisms of virus persistence in an AAV-based mouse model of chronic HBV infection

$491,566
Michael D Robek · Albany Medical College · R01 · FY2024 · AI

Human mechanisms of virus persistence in an AAV-based mouse model of chronic HBV infection

$491,566
Michael D Robek · Albany Medical College · R01 · FY2022 · AI

Regulation of glycogen in health and disease

$491,492
Alan R. Saltiel · University Of California, San Diego · R01 · FY2023 · DK

Yale Drug Abuse, Addiction, and HIV Research Scholars (Yale-DAHRS)

$491,490
Gail D'onofrio · Yale University · K12 · FY2015 · DA

Epigenetic Regulation of Mitochondrial Homeostasis and Energy Metabolism

$491,460
Qin Yang · University Of California-Irvine · R01 · FY2023 · DK

TRAINING IN PEDIATRIC GASTROENTEROLOGY AND NUTRITION

$491,446
Wayne Lencer · Boston Children'S Hospital · T32 · FY2012 · DK

CELLULAR MECHANISMS OF SEPSIS AND ORGAN FAILURE

$491,400
Richard Samuel Hotchkiss · Washington University · R01 · FY2012 · GM

CELLULAR MECHANISMS OF SEPSIS AND ORGAN FAILURE

$491,399
Richard Samuel Hotchkiss · Washington University · R01 · FY2011 · GM

Understanding mechanisms of liver carcinogenesis following developmental BPA exposure

$491,377
Caren Weinhouse · Oregon Health & Science University · R01 · FY2025 · ES

Argininosuccinate lyase is an essential regulator of systemic nitric oxide produc

$491,315
Brendan Hl Lee · Baylor College Of Medicine · R01 · FY2015 · DK

Argininosuccinate lyase is an essential regulator of systemic nitric oxide produc

$491,315
Brendan Hl Lee · Baylor College Of Medicine · R01 · FY2014 · DK

Costimulation and Regulation of Anti-Microbial Immunity

$491,178
Arlene H Sharpe · Harvard Medical School · P01 · FY2012 · AI

Growth Hormone Regulation of Sex Differences in Liver Metabolism

$491,118
David J Waxman · Boston University (Charles River Campus) · R01 · FY2019 · DK